Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.

Autoimmunity reviews - 1 Dec 2024

Balistreri Carmela Rita, Vinciguerra Claudia, Magro Daniele, Di Stefano Vincenzo, Monastero Roberto

Abstract excerpt

Predicting the onset, progression, and outcome of rare and chronic neurological diseases, i.e. neuromuscular diseases, is an important goal for both clinicians and researchers and should guide clinical decision-making and personalized treatment plans. A prime example is myasthenia gravis (MG), an antibody-mediated disease that affects multiple components of the postsynaptic membrane, impairing neuromuscular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiomics

Share to Myasthenia Gravis

Share to Myasthenia Gravis and Thymoma

Share to Phenotype

Share to Precision Medicine

Share to Prognosis

Source

Identifiers

PMID: 39426579
DOI: 10.1016/j.autrev.2024.103669

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.PMID 39426579Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read ↗

Emerging Roles of Dysregulated MicroRNAs in Myasthenia GravisSemantic proximity Read ↗

A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.Semantic proximity Read ↗

Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment AdvancementsSemantic proximity Read ↗

Myasthenia gravis: from autoantibodies to therapy.Semantic proximity Read ↗

The epidemiology of myasthenia gravis.Semantic proximity Read ↗

Clinical and Demographic Features of Distal Extremity Weakness in Myasthenia Gravis - A Scoping ReviewSemantic proximity Read ↗

Myasthenia gravis and related disorders: Pathology and molecular pathogenesisSemantic proximity Read ↗

Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A reviewSemantic proximity Read ↗

Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis.Semantic proximity Read ↗

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.